Amgen's Tarlatamab Approved by UK Regulator to Treat Lung Cancer
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
Pre-market 09:26:50 am | |||
293.54 USD | -1.42% |
|
296.75 | +1.09% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration